AFP and neoplasm: Patients with high pretreatment levels of AFP and PIVKA-II experienced a significantly higher incidence of tumor recurrence after curative treatment [20, 25], associated with the more unfavorable tumor characteristics of patients with higher levels of AFP and PIVKA-II [20, 21].